STOKE THERAPEUTICS INC (STOK) Forecast, Price Target & Analyst Ratings

NASDAQ:STOKUS86150R1077

Current stock price

32.74 USD
+0.75 (+2.34%)
At close:
32.74 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for STOKE THERAPEUTICS INC (STOK).

Forecast Snapshot

Consensus Price Target

Price Target
$43.96
+ 34.28% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.84
Revenue Estimate
6.457M

ChartMill Buy Consensus

Rating
87.78%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$43.96
Upside
+ 34.28%
From current price of $32.74 to mean target of $43.96, Based on 18 analyst forecasts
Low
$30.30
Median
$40.29
High
$63.00

Price Target Revisions

1 Month
7.54%
3 Months
18.75%

Price Target Summary

18 Wall Street analysts provided a forecast for the next 12 months for STOK. The average price target is 43.96 USD. This implies a price increase of 34.28% is expected in the next year compared to the current price of 32.74.
The average price target has been revised upward by 18.75% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

STOK Current Analyst RatingSTOK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

STOK Historical Analyst RatingsSTOK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
87.78%
STOK was analyzed by 18 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about STOK.
In the previous month the buy percentage consensus was at a similar level.
STOK was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-20Canaccord GenuityMaintains Buy -> Buy
2026-03-19BTIGReiterate Buy -> Buy
2026-03-18Chardan CapitalMaintains Buy -> Buy
2026-03-18WedbushMaintains Outperform -> Outperform
2026-03-17NeedhamMaintains Buy -> Buy
2026-03-17WedbushMaintains Outperform -> Outperform
2026-02-24Wolfe ResearchInitiate Outperform
2026-01-12WedbushMaintains Outperform -> Outperform
2026-01-05Chardan CapitalMaintains Buy -> Buy
2026-01-05Canaccord GenuityMaintains Buy -> Buy
2025-12-15HC Wainwright & Co.Maintains Buy -> Buy
2025-11-05BTIGReiterate Buy -> Buy
2025-11-05WedbushMaintains Outperform -> Outperform
2025-11-05Canaccord GenuityMaintains Buy -> Buy
2025-11-03JP MorganMaintains Neutral -> Neutral
2025-10-13BTIGMaintains Buy -> Buy
2025-10-10NeedhamMaintains Buy -> Buy
2025-08-13Chardan CapitalMaintains Buy -> Buy
2025-08-13WedbushMaintains Outperform -> Outperform
2025-07-18JefferiesInitiate Buy
2025-07-01NeedhamReiterate Buy -> Buy
2025-05-14HC Wainwright & Co.Maintains Buy -> Buy
2025-04-09NeedhamReiterate Buy -> Buy
2025-03-19Chardan CapitalMaintains Buy -> Buy
2025-03-19HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.84
Revenue Estimate
6.457M
Revenue Q2Q
-95.93%
EPS Q2Q
-142.60%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
-8.34%
Revenue (3 Months)
1.43%
EPS (1 Month)
-0.24%
EPS (3 Months)
1.70%

Next Earnings Summary

STOK is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.84 USD and the consensus revenue estimate is 6.46M USD.
The next earnings revenue estimate has been revised upward by 1.43% in the past 3 months.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
STOK revenue by date.STOK revenue by date.
12.41M8.78M
-29.25%
36.555M
316.34%
193.33M
428.87%
34.365M
-82.22%
62.56M
82.05%
127.4M
103.64%
343.63M
169.73%
549.22M
59.83%
751.08M
36.75%
908.66M
20.98%
1.046B
15.11%
EBITDA
YoY % growth
STOK ebitda by date.STOK ebitda by date.
-102.81M
-20.81%
-112.304M
-9.23%
-99.195M
11.67%
10.099M
110.18%
-185.599M
-1,937.80%
-189.293M
-1.99%
-118.503M
37.40%
233.37M
296.93%
400.56M
71.64%
588.18M
46.84%
726.56M
23.53%
929.65M
27.95%
EBIT
YoY % growth
STOK ebit by date.STOK ebit by date.
-104.36M
-21.25%
-114.773M
-9.98%
-101.372M
11.68%
-7.003M
93.09%
-217.867M
-3,011.04%
-215.328M
1.17%
-157.981M
26.63%
72.277M
145.75%
244.46M
238.23%
419.03M
71.41%
560.01M
33.64%
657.62M
17.43%
Operating Margin
STOK operating margin by date.STOK operating margin by date.
-840.93%-1,307.21%-277.31%-3.62%-633.98%-344.19%-124.00%21.03%44.51%55.79%61.63%62.87%
EPS
YoY % growth
STOK eps by date.STOK eps by date.
-2.60
-11.59%
-2.37
8.69%
-1.68
29.23%
0.19
97.62%
-3.10
-7,657.89%
-2.59
16.44%
-1.84
28.88%
0.05
102.45%
2.54
5,528.22%
3.76
47.86%
5.20
38.25%
6.81
31.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.84
-142.60%
-0.85
-112.33%
-0.89
-36.95%
-0.90
6.97%
-0.98
-15.72%
-0.99
-16.77%
-0.92
-3.85%
-0.86
4.45%
Revenue
Q2Q % growth
6.457M
-95.93%
6.709M
-51.44%
6.845M
-35.62%
8.115M
478.82%
7.65M
18.48%
7.65M
14.03%
7.65M
11.76%
7.65M
-5.73%
EBITDA
Q2Q % growth
-51.63M
-146.22%
-53.085M
-101.26%
-54.035M
-29.50%
-52.572M
-19.40%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-55.491M
-149.88%
-56.935M
-108.55%
-58.22M
-35.11%
-61.007M
-24.94%
-66.069M
-19.06%
5.549M
109.75%
-63.899M
-9.75%
-58.261M
4.50%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

STOK Yearly Revenue VS EstimatesSTOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
STOK Yearly EPS VS EstimatesSTOK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-258.58%
EPS Next 5 Year
130.86%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-12.98%
Revenue Next 5 Year
23.22%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-15.58%
EBIT Next 5 Year
31.31%

STOKE THERAPEUTICS INC / STOK Forecast FAQ

Can you provide the average price target for STOKE THERAPEUTICS INC stock?

18 analysts have analysed STOK and the average price target is 43.96 USD. This implies a price increase of 34.28% is expected in the next year compared to the current price of 32.74.

Can you provide the upcoming earnings date for STOKE THERAPEUTICS INC?

STOKE THERAPEUTICS INC (STOK) will report earnings on 2026-05-11.

What are the consensus estimates for STOK stock next earnings?

The consensus EPS estimate for the next earnings of STOKE THERAPEUTICS INC (STOK) is -0.84 USD and the consensus revenue estimate is 6.46M USD.

Can you provide the analyst count for STOKE THERAPEUTICS INC stock?

The number of analysts covering STOKE THERAPEUTICS INC (STOK) is 18.